 Katherine Hisert
Concepts (117)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cystic Fibrosis | 16 | 2023 | 964 | 3.540 |
Why?
| | Quinolones | 4 | 2022 | 98 | 2.020 |
Why?
| | Cystic Fibrosis Transmembrane Conductance Regulator | 7 | 2023 | 288 | 1.660 |
Why?
| | Aminophenols | 5 | 2023 | 112 | 1.640 |
Why?
| | Mycobacterium Infections, Nontuberculous | 4 | 2023 | 334 | 1.040 |
Why?
| | Mycobacterium abscessus | 2 | 2023 | 97 | 1.000 |
Why?
| | Sputum | 5 | 2021 | 290 | 0.850 |
Why?
| | Macrophages | 5 | 2023 | 1324 | 0.820 |
Why?
| | Lung | 10 | 2023 | 3664 | 0.690 |
Why?
| | Cell Separation | 1 | 2019 | 296 | 0.640 |
Why?
| | Respiratory Tract Infections | 2 | 2021 | 331 | 0.600 |
Why?
| | Pseudomonas Infections | 4 | 2021 | 193 | 0.570 |
Why?
| | Proteome | 2 | 2019 | 353 | 0.560 |
Why?
| | Pseudomonas aeruginosa | 4 | 2021 | 305 | 0.540 |
Why?
| | Flow Cytometry | 1 | 2019 | 1085 | 0.540 |
Why?
| | Inflammation | 5 | 2022 | 2566 | 0.500 |
Why?
| | Mycobacterium tuberculosis | 3 | 2022 | 266 | 0.460 |
Why?
| | Chloride Channel Agonists | 2 | 2023 | 58 | 0.370 |
Why?
| | Bacterial Proteins | 3 | 2019 | 759 | 0.370 |
Why?
| | Nontuberculous Mycobacteria | 3 | 2023 | 206 | 0.360 |
Why?
| | Mutation | 3 | 2023 | 3457 | 0.330 |
Why?
| | Interferon-gamma | 2 | 2011 | 736 | 0.270 |
Why?
| | Cyclic GMP | 1 | 2005 | 109 | 0.260 |
Why?
| | Zymosan | 1 | 2023 | 64 | 0.230 |
Why?
| | Salmonella typhimurium | 1 | 2005 | 174 | 0.230 |
Why?
| | Phagocytosis | 2 | 2023 | 364 | 0.230 |
Why?
| | Tuberculosis, Pulmonary | 1 | 2004 | 112 | 0.230 |
Why?
| | Benzodioxoles | 1 | 2023 | 84 | 0.220 |
Why?
| | Humans | 18 | 2023 | 118974 | 0.200 |
Why?
| | Bacteriophages | 1 | 2022 | 76 | 0.190 |
Why?
| | Polysaccharides, Bacterial | 1 | 2021 | 69 | 0.190 |
Why?
| | Mucus | 1 | 2020 | 54 | 0.190 |
Why?
| | Anti-Bacterial Agents | 6 | 2022 | 1510 | 0.190 |
Why?
| | Animals | 8 | 2023 | 33381 | 0.170 |
Why?
| | Stem Cells | 1 | 2023 | 559 | 0.170 |
Why?
| | Toll-Like Receptors | 1 | 2019 | 167 | 0.170 |
Why?
| | Respiratory Function Tests | 1 | 2019 | 526 | 0.160 |
Why?
| | Inovirus | 1 | 2016 | 1 | 0.150 |
Why?
| | DNA Transposable Elements | 3 | 2011 | 102 | 0.150 |
Why?
| | Mice | 6 | 2023 | 15520 | 0.140 |
Why?
| | Delivery of Health Care | 1 | 2023 | 867 | 0.140 |
Why?
| | Monocytes | 2 | 2016 | 513 | 0.140 |
Why?
| | Cell Survival | 1 | 2019 | 1047 | 0.140 |
Why?
| | Infection Control | 1 | 2015 | 135 | 0.120 |
Why?
| | Immunity, Innate | 1 | 2019 | 745 | 0.120 |
Why?
| | Neutrophils | 1 | 2019 | 1233 | 0.120 |
Why?
| | Cross Infection | 1 | 2015 | 205 | 0.110 |
Why?
| | Gene Expression Profiling | 1 | 2019 | 1597 | 0.110 |
Why?
| | Disease Outbreaks | 1 | 2015 | 322 | 0.110 |
Why?
| | Adult | 6 | 2019 | 31512 | 0.100 |
Why?
| | Rats | 1 | 2020 | 5392 | 0.100 |
Why?
| | Quality of Life | 1 | 2022 | 2366 | 0.100 |
Why?
| | Polyketide Synthases | 1 | 2011 | 4 | 0.100 |
Why?
| | Mupirocin | 1 | 2010 | 7 | 0.100 |
Why?
| | Staphylococcal Skin Infections | 1 | 2010 | 30 | 0.100 |
Why?
| | Adipose Tissue | 1 | 2014 | 606 | 0.090 |
Why?
| | Genetic Variation | 1 | 2015 | 926 | 0.090 |
Why?
| | AIDS-Related Opportunistic Infections | 1 | 2010 | 113 | 0.090 |
Why?
| | Apoptosis | 1 | 2019 | 2484 | 0.090 |
Why?
| | Nitric Oxide Synthase | 2 | 2011 | 225 | 0.080 |
Why?
| | Male | 9 | 2022 | 57801 | 0.080 |
Why?
| | Mice, Inbred C57BL | 4 | 2016 | 4908 | 0.080 |
Why?
| | Tomography, X-Ray Computed | 1 | 2017 | 2436 | 0.080 |
Why?
| | Lipids | 1 | 2011 | 607 | 0.080 |
Why?
| | Staphylococcus aureus | 1 | 2010 | 394 | 0.070 |
Why?
| | Biofilms | 2 | 2021 | 231 | 0.070 |
Why?
| | Molecular Sequence Data | 2 | 2015 | 2871 | 0.070 |
Why?
| | Mutagenesis, Insertional | 1 | 2005 | 61 | 0.070 |
Why?
| | Sequence Alignment | 1 | 2005 | 336 | 0.060 |
Why?
| | Nitric Oxide Synthase Type II | 1 | 2004 | 165 | 0.060 |
Why?
| | Mutagenesis | 1 | 2004 | 176 | 0.060 |
Why?
| | Hydrogen Peroxide | 1 | 2005 | 305 | 0.060 |
Why?
| | Female | 6 | 2019 | 61565 | 0.060 |
Why?
| | Expectorants | 1 | 2021 | 24 | 0.050 |
Why?
| | Amino Acid Sequence | 1 | 2005 | 2071 | 0.050 |
Why?
| | Phenotype | 2 | 2022 | 3003 | 0.050 |
Why?
| | C-Reactive Protein | 1 | 2022 | 360 | 0.050 |
Why?
| | Armadillo Domain Proteins | 1 | 2019 | 5 | 0.050 |
Why?
| | Drug Resistance, Bacterial | 1 | 2021 | 155 | 0.050 |
Why?
| | Glyoxylates | 1 | 2019 | 9 | 0.040 |
Why?
| | DNA, Bacterial | 1 | 2021 | 314 | 0.040 |
Why?
| | Cytoskeletal Proteins | 1 | 2019 | 146 | 0.040 |
Why?
| | Carbon | 1 | 2019 | 170 | 0.040 |
Why?
| | Lactic Acid | 1 | 2019 | 282 | 0.040 |
Why?
| | Proto-Oncogene Proteins c-akt | 1 | 2019 | 420 | 0.040 |
Why?
| | Down-Regulation | 1 | 2019 | 627 | 0.040 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2019 | 404 | 0.040 |
Why?
| | Disease Progression | 1 | 2022 | 2490 | 0.030 |
Why?
| | Palmitates | 1 | 2014 | 19 | 0.030 |
Why?
| | Mice, Obese | 1 | 2014 | 58 | 0.030 |
Why?
| | Culture Media, Conditioned | 1 | 2014 | 112 | 0.030 |
Why?
| | Antigens, Surface | 1 | 2014 | 156 | 0.030 |
Why?
| | PPAR gamma | 1 | 2014 | 188 | 0.030 |
Why?
| | Membrane Proteins | 1 | 2019 | 1055 | 0.030 |
Why?
| | Sequence Analysis, DNA | 1 | 2015 | 755 | 0.030 |
Why?
| | Biomarkers | 1 | 2022 | 3588 | 0.030 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2014 | 394 | 0.030 |
Why?
| | Lipid Metabolism | 1 | 2014 | 477 | 0.020 |
Why?
| | Cell Wall | 1 | 2011 | 53 | 0.020 |
Why?
| | Methicillin Resistance | 1 | 2010 | 19 | 0.020 |
Why?
| | Ointments | 1 | 2010 | 25 | 0.020 |
Why?
| | Autophagy | 1 | 2014 | 315 | 0.020 |
Why?
| | Administration, Intranasal | 1 | 2010 | 79 | 0.020 |
Why?
| | Cell Membrane | 1 | 2014 | 710 | 0.020 |
Why?
| | Amino Acid Substitution | 1 | 2011 | 276 | 0.020 |
Why?
| | Point Mutation | 1 | 2011 | 228 | 0.020 |
Why?
| | Adaptive Immunity | 1 | 2011 | 161 | 0.020 |
Why?
| | Glucose | 1 | 2014 | 953 | 0.020 |
Why?
| | Drug Administration Schedule | 1 | 2010 | 736 | 0.020 |
Why?
| | Genetic Predisposition to Disease | 1 | 2015 | 2275 | 0.020 |
Why?
| | Cells, Cultured | 1 | 2014 | 4077 | 0.020 |
Why?
| | Double-Blind Method | 1 | 2010 | 1687 | 0.020 |
Why?
| | Insulin | 1 | 2014 | 2162 | 0.020 |
Why?
| | United States | 1 | 2019 | 12555 | 0.010 |
Why?
| | Young Adult | 1 | 2015 | 10793 | 0.010 |
Why?
| | Middle Aged | 1 | 2019 | 27617 | 0.010 |
Why?
| | Treatment Outcome | 1 | 2010 | 9342 | 0.010 |
Why?
|
|
Hisert's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|